Associated Papers
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance.
Wang LM et al.
Embo Molecular Medicine, 2023
36652375 (PubMed )
Supplement: EMMM-15-e16235-s006.pdf
Select a paper to view details